A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study (Q83456069)
Jump to navigation
Jump to search
scientific article published on 19 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study |
scientific article published on 19 February 2011 |
Statements
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: a phase I/II study (English)
C Villanueva
A Awada
M Campone
J P Machiels
T Besse
E Magherini
F Dubin
19 February 2011